Todd C. Brady - 07 Sep 2023 Form 4 Insider Report for Aldeyra Therapeutics, Inc. (ALDX)

Role
President and CEO, Director
Signature
/s/ Todd C. Brady
Issuer symbol
ALDX
Transactions as of
07 Sep 2023
Net transactions value
-$382,159
Form type
4
Filing time
11 Sep 2023, 17:42:20 UTC
Previous filing
11 May 2023
Next filing
12 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALDX Common Stock Options Exercise $106,030 +192,084 +13% $0.5520* 1,647,369 07 Sep 2023 Direct
transaction ALDX Common Stock Options Exercise $18,190 +32,953 +2% $0.5520* 1,680,322 07 Sep 2023 Direct
transaction ALDX Common Stock Options Exercise $26,508 +48,021 +2.9% $0.5520* 1,728,343 07 Sep 2023 Direct
transaction ALDX Common Stock Tax liability $532,887 -73,807 -4.3% $7.22 1,654,536 07 Sep 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALDX Stock Option (right to buy) Options Exercise $0 -192,084 -100% $0.000000* 0 07 Sep 2023 Common Stock 192,084 $0.5520 Direct F2
transaction ALDX Stock Option (right to buy) Options Exercise $0 -32,953 -100% $0.000000* 0 07 Sep 2023 Common Stock 32,953 $0.5520 Direct F2
transaction ALDX Stock Option (right to buy) Options Exercise $0 -48,021 -100% $0.000000* 0 07 Sep 2023 Common Stock 48,021 $0.5520 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the exercise of the stock options.
F2 The stock option is fully vested.